Grablyn-M Capsule is a combination pharmaceutical formulation containing Methylcobalamin 750 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters and alleviating neuropathic pain, seizures, and anxiety. The synergistic action of these two components provides effective relief from symptoms associated with diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and other neuropathic conditions. Grablyn-M Capsule is typically administered orally, with dosage adjusted based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, gastrointestinal disturbances, and peripheral edema. Caution is advised in patients with renal impairment, and it should be used under medical supervision to monitor efficacy and potential side effects. This combination therapy offers a comprehensive approach to neuropathic pain management by addressing both symptomatic relief and nerve health restoration.